Eli Lilly (LLY +1.53%) gained major approval for a new weight-loss treatment poised to generate billions in revenue.
*Stock prices used were the afternoon prices of April 3, 2026. The video was published on April 5, 2026.
Read Next
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.